Accord Healthcare

Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
 

DRUG
REACTION
REPORT

report

GROWTH’S IN OUR NATURE

Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.

Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.

01

TRULY MULTINATIONAL

Accord has one of the most extensive sales, marketing and distribution networks in Europe. Accord now supplies products in close to 65 EMENA markets.

02

A COMPLETE APPROACH

Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.

 

03

EUROPEAN FOCUS

Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.

04

News

11-10-2019

ACCORD HEALTHCARE LAUNCH PRASUGREL

Accord Healthcare is delighted to announce the launch of Prasugrel Accord 10 mg which is available in a pack size of 28 tablets.  

07-10-2019

ACCORD SPONSOR THE DIARMUID O’DONOVAN SPECIAL RECOGNITION AWARD

Accord are delighted to have sponsored the Diarmuid O’Donovan Special Recognition Award  at the recent Life Awards.

Damien McCormack, Accord Key Account Manager, presented the award to Sarah O’Riordan from Fogarty’s Pharmacy, Kilmallock, Co. Limerick.